Serum from Sydenham's chorea patients modifies intracellular calcium levels in PC12 cells by a complement-independent mechanism
✍ Scribed by Antonio L. Teixeira Jr; Melissa M. Guimarães; Marco Aurélio Romano-Silva; Francisco Cardoso
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 53 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The proposed pathogenesis of Sydenham's chorea (SC) is an autoantibody‐mediated basal ganglia dysfunction. Our study has shown that incubation of PC12 cells with complement‐inactivated serum from SC patients was associated with a significant increase in Ca^2+^ levels evoked by KCl stimulus (mean ± SEM, 341.0 ± 8.7% of fluorescence intensity, arbitrary units) when compared with incubation with control serum (313.8 ± 8.7% of fluorescence intensity, arbitrary units; P = 0.01). The increase in Ca^2+^ levels determined by SC patients sera correlated directly with the enzyme‐linked immunosorbent assay optical density values for anti–basal ganglia antibodies. Our study supports the hypothesis that antibodies against basal ganglia in SC may cause their dysfunction. © 2005 Movement Disorder Society